Corcept Therapeutics Incorporated Revenue 2000–2025
Corcept Therapeutics Incorporated reported $761.41M of revenue for fiscal 2025. That was 12.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +115.2%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $761.41M | +12.8% |
| FY 2024 | $675.04M | +39.9% |
| FY 2023 | $482.38M | +20.0% |
| FY 2022 | $401.86M | +9.8% |
| FY 2021 | $365.98M | +3.4% |
| FY 2020 | $353.87M | +15.5% |
| FY 2019 | $306.49M | +22.0% |
| FY 2018 | $251.25M | +57.8% |
| FY 2017 | $159.20M | +95.8% |
| FY 2016 | $81.32M | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | -100.0% |
| FY 2009 | $29,000 | — |
| FY 2008 | $0 | — |
| FY 2007 | $0 | — |
| FY 2006 | $0 | — |
| FY 2005 | $0 | — |
| FY 2004 | $0 | — |
| FY 2003 | $0 | — |
| FY 2002 | $0 | — |
| FY 2001 | $0 | — |
| FY 2000 | $0 | — |
Source: Corcept Therapeutics Incorporated SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CORT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Corcept Therapeutics Incorporated reported $761.41M of revenue for fiscal 2025. That was 12.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +115.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Corcept Therapeutics Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCorcept Therapeutics Incorporated — frequently asked questions
What is Corcept Therapeutics Incorporated's revenue?
Corcept Therapeutics Incorporated (CORT) reported revenue of $761.41M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Corcept Therapeutics Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.